옵션 체인은 다양한 행사가격과 만기일에 대한 Nomura Holdings의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Nomura Holdings에 대한 시장 심리를 평가합니다..

Nomura Holdings (NYSE:NMR) 주식, 옵션 체인

Nomura Holdings

Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions worldwide including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking which is engaged in advisory, financing, and solutions businesses.

Crime,-,Prison,Cell,Bars

News

Legal

Global

General

AAPL

MSFT

아케고스 캐피탈 매니지먼트의 창립자인 빌 황이 수요일(20일)에 사기 및 시장조작 혐으로 2021년의 극적인 파산과 관련하여 18년의 징역형을 선고받았다.세부 사항: 빌 황은 뉴욕의 앨빈 헬러스타인 미국 지방법원 판사로부터 검찰이 구형한 21년보다 약간 적은 형량인 18년을 선고받았다.

크레디트스위스 붕괴와 관련된 한국계 투자가 빌 황, 사기 및 시장조작 혐의로 징역 18년

Nvidia Earnings 'More Important' Than Jerome Powell's Jackson Hole Speech For Wall Street, Says Expert: 'Not Even Going To Tell You What He's Going To Do After That…'

Large Cap

Movers

Trading Ideas

COHR

CVNA

DELL

DKNG

MRVL

NVDA

SBUX

SMCI

ULTA

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 9월 9일부터 치폴레 멕시칸 그릴(NYSE:CMG)의 CEO 겸 회장인 브라이언 니콜(Brian Niccol)이 스타벅스(NASDAQ:SBUX)의 새로운 회장 겸 CEO로 임명되었다고 발표한 후 스타벅스의 주가는 24.08% 상승했다.

엔비디아, 스타벅스 및 델은 지난주 최고 성과를 보여준 10개 대형주 중 일부 (8월 11일-8월 17일)

Nomura Holdings Inc ADR American Depositary Shares

Nomura Holdings Inc

Numeraire - United States Dollar

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics Inc

NEMAURA MEDICAL INC by Nemaura Medical, Inc.

Nemaura Medical Inc

NAMIBIA CRITICAL METALS by Namibia Critical Metals Inc.

Namibia Critical Metals Inc

Newmark Group, Inc. - Class A Common Stock

Newmark Group Inc

Numeral Ltd

NATIONAL MILK RECORDS PLC by National Milk Records Plc.

NAMURA SHIPBUILD CO ORD by Namura Shipbuilding Co. Ltd.

Namura Shipbuilding Co Ltd

Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) reported quarterly earnings of $0.15 per share. This is a 25 percent increase over earnings of $0.12 per share from the same period last year. The company reported $2.97 billion in sales this quarter. This is a 1.00 percent decrease over sales of $3.00 billion the same period last year.

Earnings

Nomura Holdings Q4 EPS $0.15 Up From $0.12 YoY, Sales $2.97B Down From $3.00B YoY

On Tuesday, Nomura Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) disclosed a definitive agreement to acquire Macquarie Group, Ltd.&#8217;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MCQEF#OTC">MCQEF</a>) public asset management operations in the U.S. and Europe in an <a target="_blank" href="https://www.benzinga.com/topic/why-its-moving" rel="noreferrer noopener">all-cash deal valued at $1.8 billion</a>.
The deal includes around $180 billion in assets under management from retail <a target="_blank" href="https://www.nomuraholdings.com/news/nr/holdings/20250422/20250422.html" rel="noreferrer noopener">and</a> institutional clients, spanning equity, fixed income, and multi-asset strategies.
The transaction is expected to close by the year-end, pending regulatory approvals and customary closing conditions.
This acquisition is projected to enhance Nomura&#8217;s global reach and capabilities of its Investment Management Division, which currently oversees approximately $590 billion in assets.
Following the deal&#8217;s completion, Nomura&#8217;s total assets under management are expected to rise to roughly $770 billion, with over 35% of those assets <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">managed for clients outside Japan</a>.
The transaction will also establish the company&#8217;s substantial operational base in Philadelphia.
Kentaro Okuda, Nomura President and Group CEO, said &#8220;This acquisition will align with our 2030 global growth and diversification ambitions to invest in stable, high margin businesses,&#8221;
As of December 31, 2024, cash and cash deposits stood <a target="_blank" href="https://www.nomuraholdings.com/investor/summary/financial/data/2025_3q_pres.pdf" rel="noreferrer noopener">at </a>5.575 billion Yen.
Price Action: NMR shares are up 2.75% at $5.600&nbsp;at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/upgrades/25/04/44935871/self-storage-reits-score-upgrade-from-bofa-analyst-8-decline-in-new-construction-helps-sector" target="_blank" rel="noreferrer noopener">Self-Storage REITs Score Upgrade From BofA Analyst: 8% Decline In New Construction Helps Sector</a></li>
</ul>
Photo via Shutterstock

Equities

MCQEF

Nomura Eyes Global Growth With $1.8 Billion Macquarie Asset Buyout, Targets Growing AUM To $770 Billion

Reported Earlier, Nomura Plans To Fully Acquire Stock Of Three Companies That Operate Macquarie's U.S. And European Public Asset Management Business For An All-cash Price Of $1.8B

WIIM

CRBG

ENVA

FRHC

HLNE

Janus Henderson Group plc Ordinary Shares

LPLA

NTRS

PIPR

SNEX

SPGI

VCTR

Shares of companies within the broader financial sector are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

DGICB

PMAX

ZBAO

Shares of companies within the broader financial sector are trading lower in response to President Trump's sweeping Liberation tariffs and retaliatory responses. The sector is now facing greater macroeconomic uncertainty and recession fears.

ARES

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BRDG

EMCG

FUTU

HOOD

IBKR

LPRO

MKTW

NDAQ

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

SCHW

STEP

TROW

Shares of capital market companies are trading lower as markets react to President Trump's announcement of sweeping tariffs.

ALLY

BBDO

BBVA

BSBR

CNCK

GDOT

HBAN

HSBC

INTR

ITUB

JFIN

LMND

MUFG

QFIN

ROOT

SMFG

SOFI

TIGR

Shares of banks and financial services stocks are trading lower following greater-than-expected inflation data measured through the PCE price index for February, while personal spending missed estimates. Additionally, recent tariff announcements may be weighing on equities.

CNFR

HRTG

Shares of banks and financial services stocks are trading higher amid an overall market rebound following recent weakness.

Nomura Holdings shares are trading higher following Q3 financial results.

Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) reported quarterly earnings of $0.22 per share which met the analyst consensus estimate. This is a 100 percent increase over earnings of $0.11 per share from the same period last year. The company reported $3.30 billion in sales this quarter. This is a 21.66 percent increase over sales of $2.71 billion the same period last year.

Nomura Holdings Q3 EPS USD$0.22, Inline, Sales USD $3.30B Up From USD $2.71B YoY

ALGN

AMSC

AOSL

APPS

ARAY

ARCC

ASGN

ASYS

AZTA

BARK

BLBD

CENT

CENTA

CMRE

CNMD

CNXN

CPAY

CPRI

CRTO

CSGS

CTSH

CTVA

DGII

DLHC

ENSG

EQNR

EZPW

FORM

GEOS

HOLX

KMPR

LFVN

LSAK

LUCK

LVWR

MSTR

MTRX

MUSA

NOTV

NTGR

NVST

NWSA

ODFL

ORLY

PAHC

PFGC

Earnings Scheduled For February 5, 2025

It is all true.
The market is priced at ridiculous levels.
The current multiples of earnings, cash flow, assets, and dividends of the S&amp;P 500 (Ticker: SPY) imply that we live in a perfect world and perfection will continue to grow at a double-digit rate.
We do not live in a perfect world.
The bond market, usually the far brighter and less emotional market, has been showing great concern and a smudge of outright fear in recent weeks. It has reentered a downtrend even as stocks went higher.
Should we just sell and hide under a rock on top of a mountain somewhere until the headlines improve?
Probably not.
If we have learned nothing else, it is that markets can remain irrational, unrealistic, and overpriced for a very long time.
What we can do is become cautious.
Avoid companies where insiders are selling as the price declines.
Avoid stocks that are being sold by smart money investors with outstanding track records.
Flipping that over, if you are looking to put money to work, look for companies where insiders are making large open-market purchases of shares of the companies they manage.
Look for companies where investors with great track records are stepping up and establishing new company positions.
I recently sat down to review institutional buying and selling activity, and a couple of purchases caught my eye.
One such smart money buy was a biotech company.
Let me be upfront and say that I know nothing about biotechnology.
I am not a doctor, I have never played a doctor on television, and I generally avoid small-cap biotech stocks because that is where money goes to die.
There have been a handful of exceptions over the years, and they were all the result of noticing that a very smart, very successful investor had bought a lot of stock.
I noticed that Harris Kupperman of Praetorian Capital had purchased a 5.5% stake in Immune Bio (Ticker: INMB).
Kupperman, or JKuppy as he prefers to be called apparently, is not everyone&#8217;s cup of tea.
He can come across as brash, opinionated, and a tad arrogant.
He runs part of his fund in deep-value stocks and the other half in special situations.
It is almost like looking in a personality mirror.
He is also very good at what he does.
Kupperman runs his fund to do okay in what he calls standard years and to really push the edge when he feels he has uncovered opportunities in deeply undervalued markets and sectors.
It is working.
Since 2019, his fund is up a little over 700%.
Immune Bio is working on developing drugs using its core research that could help treat depression and Alzheimer&#8217;s.
Both are massive markets that could lead to substantial partnership opportunities or licensing deals for a company that progresses in developing a successful drug.
The folks at Praetorian are not the only ones excited about the stock. Raymond James analyst Gary Nachman recently wrote a favorable report with an $18 price target for shares of Immune Bio.
That is almost three times the current stock price.
The true test of another intelligence is how much they agree with me, and a closer peek into Praetorian&#8217;s portfolio at the end of the third quarter shows that he bought shares of one of my favorite Japanese firms, Nomura (Ticker: NMR).
Nomura has had one of those years that just naturally attracts my attention.
One staffer tried to manipulate the bond market, and the firm had to pay a fine and temporarily lost its status as a primary dealer.
Then, a Nomura staffer was arrested for attempting to murder an elderly client.
These are not the kind of headlines that attract enthusiastic buyers of your stock.
None of this impacts a firm of Nomura&#8217;s size, but it creates a cloud around the stock that creates buying opportunities.
The scandals have partially masked that business at Nomura is pretty good. Revenues are rising, and profits more than doubled, as the company reported its largest profits in four years.
The company is buying back stock and paying a cash dividend of 4.3%, rewarding shareholders with its excess cash.
The company is increasing its presence outside of Asia, focusing on wealthy markets like the Americas, India and the Middle East. Early results are promising, with solid gains in the number of customers for both wealth management and investment banking in these markets.
In spite of the strong results and positive outlook, the stock is trading at just 82% of tangible book value and less than ten times earnings.
These are uncertain times in financial markets.
There are as many possible outcomes as there are questions about what lies ahead in 2025.
Avoiding stocks where insiders and the smart money are selling and accumulating the ones they are buying can help us navigate turbulent waters profitably.

Opinion

INMB

C-Suite Buy of the Week: Executive Moves from Biotech to Banking

Archegos Capital Management founder Bill Hwang was sentenced on Wednesday to 18 years in prison for fraud and market manipulation tied to the fund's <a href="https://www.benzinga.com/news/24/05/38718096/bill-hwangs-trial-begins-over-archegos-fund-collapse-what-to-expect">dramatic collapse in 2021.&nbsp;</a>
The Details: Hwang was sentenced by U.S. District Judge Alvin Hellerstein in New York to slightly less time than the 21 years prosecutors had sought in the case. 
Hwang's lawyers had asked that he be given no prison time at all and Hwang asked the judge on Wednesday to impose a sentence that would allow him to continue to serve society. He also said that he felt "deep pain" about what happened at Archegos, according to a Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-11-20/archegos-founder-bill-hwang-sentenced-to-18-years-in-prison?sref=TBDibEcD">report.</a>
Read More: <a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks">Trump Appears &#8216;Frustrated&#8217; As Elon Musk Chimes In On Treasury Secretary, Adds More Names To Short List&nbsp;</a>
Hellerstein said Hwang's request for no jail time was "utterly ridiculous" considering the amount of money involved. 
"The amount of losses that were caused by your conduct are larger than any amount of losses I've deal with as a judge," Hellerstein said.
The judge also compared Hwang to FTX founder Sam Bankman-Fried, who received a 25-year sentence for fraud.
"What was worse? Mr. Bankman-Fried's fraud or Mr. Hwang's fraud?" Hellerstein asked.
The jury found that Hwang directed Archegos staff to relay that the firm had large positions in companies such as Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>). Archegos actually invested heavily in a small group of stocks that could be more easily manipulated. 
The collapse at Archegos contributed <a href="https://www.benzinga.com/news/22/11/29835374/troubled-lender-credit-suisse-flags-massive-loss-for-q4-as-it-speeds-up-turnaround-plans">to the demise </a>of Credit Suisse Group AG and rippled through Wall Street causing significant losses at Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), UBS Group AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>), Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) and other banks.
Former Archegos CFO Patrick Halligan was convicted alongside Hwang earlier in 2024 and will be sentenced separately in January.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a></li>
</ul>
Photo: Shutterstock

Hedge Funder Linked To Credit Suisse Collapse Gets 18 Year Prison Sentence For Fraud, Market Manipulation

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Tuesday.
Shares of Emerson Electric Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) rose sharply during Monday's session after the company reported better-than-expected fourth-quarter financial results and issued FY25 adjusted EPS guidance above estimates. Also, the company announced it increased return of capital to shareholders with plans to repurchase <a href="https://www.benzinga.com/news/earnings/24/11/41748679/emerson-electric-gains-on-q4-earnings-beat-and-fy25-growth-forecast-eyes-aspentech-buyout">approximately $2B in FY25.</a>
Net sales growth of 13% year over year to $4.62 billion, beating the consensus of $4.57 billion. Underlying sales were up 4%, and underlying orders increased by 2% in the quarter. Adjusted EPS improved 15% to $1.48, beating the consensus of $1.47.
Emerson Electric shares jumped 6.6% to $117.01 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Vimeo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) shares jumped 42.7% to $6.86 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter sales guidance above estimates.</li>
<li>Gogo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) gained 29.3% to $8.47 after the company reported better-than-expected third-quarter financial results.</li>
<li>Astera Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) rose 29.1% to $90.14 after the company reported better-than-expected third-quarter EPS and sales.</li>
<li>Aris Water Solutions Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) gained 25.8% to $20.84 following strong quarterly results.</li>
<li>Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) gained 22.4% to $50.70 after the company reported better-than-expected third-quarter financial results and issued guidance above consensus estimates.</li>
<li>UFP Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPT#NASDAQ">UFPT</a>) rose 20.7% to $335.00 after the company reported better-than-expected third-quarter financial results.</li>
<li>Lindblad Expeditions Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIND#NASDAQ">LIND</a>) gained 20.6% to $11.28 after the company reported better-than-expected third-quarter financial results.</li>
<li>DXP Enterprises Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXPE#NASDAQ">DXPE</a>) gained 18.7% to $60.45 following strong quarterly results.</li>
<li>Century Aluminum Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) gained 17.7% to $20.66 following upbeat quarterly earnings.</li>
<li>Payoneer Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYO#NASDAQ">PAYO</a>) climbed 16% to $9.88 after the company reported better-than-expected quarterly EPS and sales and raised its FY24 revenue guidance.</li>
<li>Cushman &amp; Wakefield PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWK#NYSE">CWK</a>) gained 13.2% to $14.88 after the company reported better-than-expected quarterly adjusted EPS results.</li>
<li>Ingredion Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) rose 12.6% to $150.97 following upbeat earnings.</li>
<li>Primoris Services Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NYSE">PRIM</a>) gained 10.5% to $71.11 following strong quarterly earnings.</li>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) rose 9.1% to $293.34.</li>
<li>Cummins Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) gained 8.7% to $353.91 after the company reported better-than-expected third-quarter financial results.</li>
<li>Nomura Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) rose 7.3% to $5.64 following second-quarter results.</li>
<li>Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) gained 6.8% to $149.00 after the company reported better-than-expected quarterly financial results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

Intraday Update

Markets

ALAB

ARIS

CENX

DXPE

GOGO

INGR

LIND

PAYO

PLTR

POWL

PRIM

UFPT

VMEO

Emerson Electric Posts Better-Than-Expected Results, Joins Palantir Technologies, DXP Enterprises, Cummins, Apollo Global Management And Other Big Stocks Moving Higher On Tuesday

Nomura Holdings shares are trading higher after the company reported Q2 financial results.

Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) reported quarterly earnings of $0.22 per share. This is a 175 percent increase over earnings of $0.08 per share from the same period last year. The company reported $3.25 billion in sales this quarter. This is a 23.88 percent increase over sales of $2.62 billion the same period last year.

Nomura Holdings Q2 EPS $0.22 Up From $0.08 YoY, Sales $3.25B Up From $2.62B YoY

ALTI

UPST

WENA

Shares of companies within the broader financial sector are trading lower amid overall market weakness as investors react to jobs data.

JP Morgan analyst Koki Sato assumes Nomura Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) from Neutral to Neutral.

Initiation

Analyst Ratings

JP Morgan Assumes Nomura Holdings to Neutral

FFBC

FRGE

FTFT

GOCO

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HIPO

MEGL

SLQT

TCJH

Shares of companies within the broader financial sector are trading higher amid overall market strength following Fed Chair Powell's comments about the economy and future rate cuts.

Comments

Nomura Holdings

Nomura Holdings (NMR) 옵션

Nomura Holdings (NYSE:NMR) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌